This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Life Science Software 2013: Markets And Opportunities

• DNA Microarray (Participants, n=201): Disclosures by experienced microarray end-users (DNA array, protein array, antibody array, tissue array) on their preferred bioinformatics software in the PCR field (including market brands and in-house developed systems); end-users' disclosures on the relative importance of specialist data control systems and/or specialist bioinformatics systems, alongside ten other general areas, as areas where innovation is most required in the DNA Microarray field; end-users' estimates of the breakdown of their current and future (2012 - 2015) annual budgets in percentage terms across eight general areas, including control and bioinformatics software, in the DNA microarray field.

• DNA Sequencing (Participants, n=108): Disclosures by experienced DNA sequencers on their preferred bioinformatics software in the DNA sequencing field (including market brands and in-house developed systems); end-users' disclosures on the relative importance of specialist data control systems and/or specialist bioinformatics systems, alongside ten other general areas, as areas where innovation is most required in the DNA sequencing field; end-users' estimates of the breakdown of their current and future (2012 - 2015) annual budgets in percentage terms across eight general areas, including control and bioinformatics software, in the DNA sequencing field.

• Flow Cytometry (Participants, n=262): Disclosures by experienced flow cytometry users on their preferred data analysis (off line) software in the flow cytometry field; end-users' disclosures on the relative importance of offline (analysis) software and/or online data handling software, alongside eight other general areas, where innovation is most required in the flow cytometry field; end-users' estimates of the breakdown of their current annual budgets in percentage terms across four general areas, including system control and analysis (offline) software, in the mass spectrometry field.

• Mass Spectrometry (Participants, n=567): Disclosures by experienced mass spectrometrists on their use (%) of data systems that are either part of the mass spectrometry systems supplied (i.e. integrated data systems) or alternatively, data system that are installed independently (i.e. independent data systems); type of independent data system used; type of database software used in MS applications; use of other specialist software in MS applications; end-users' disclosures on the relative importance of data systems/specialist software, alongside four other general areas, where end-users anticipate the greatest innovation over the next three years; end-users' estimates of the breakdown of their current annual budgets in percentage terms across four general areas, including data handling and specialialist software, in the mass spectrometry field.

3 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,672.60 -141.38 -0.79%
S&P 500 2,051.82 -11.33 -0.55%
NASDAQ 4,757.8790 +7.4820 0.16%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs